195 related articles for article (PubMed ID: 15626932)
1. Predicting pharmacy costs and other medical costs using diagnoses and drug claims.
Zhao Y; Ash AS; Ellis RP; Ayanian JZ; Pope GC; Bowen B; Weyuker L
Med Care; 2005 Jan; 43(1):34-43. PubMed ID: 15626932
[TBL] [Abstract][Full Text] [Related]
2. Measuring population health risks using inpatient diagnoses and outpatient pharmacy data.
Zhao Y; Ellis RP; Ash AS; Calabrese D; Ayanian JZ; Slaughter JP; Weyuker L; Bowen B
Health Serv Res; 2001 Dec; 36(6 Pt 2):180-93. PubMed ID: 16148968
[TBL] [Abstract][Full Text] [Related]
3. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population.
Sales AE; Liu CF; Sloan KL; Malkin J; Fishman PA; Rosen AK; Loveland S; Paul Nichol W; Suzuki NT; Perrin E; Sharp ND; Todd-Stenberg J
Med Care; 2003 Jun; 41(6):753-60. PubMed ID: 12773841
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic, pharmacy-based, and self-reported health measures in risk equalization models.
Stam PJ; van Vliet RC; van de Ven WP
Med Care; 2010 May; 48(5):448-57. PubMed ID: 20393368
[TBL] [Abstract][Full Text] [Related]
5. Finding future high-cost cases: comparing prior cost versus diagnosis-based methods.
Ash AS; Zhao Y; Ellis RP; Schlein Kramer M
Health Serv Res; 2001 Dec; 36(6 Pt 2):194-206. PubMed ID: 16148969
[TBL] [Abstract][Full Text] [Related]
6. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
7. The utility of extended longitudinal profiles in predicting future health care expenditures.
Cohen SB; Ezzati-Rice T; Yu W
Med Care; 2006 May; 44(5 Suppl):I45-53. PubMed ID: 16625064
[TBL] [Abstract][Full Text] [Related]
8. Risk-adjusted capitation based on the Diagnostic Cost Group Model: an empirical evaluation with health survey information.
Lamers LM
Health Serv Res; 1999 Feb; 33(6):1727-44. PubMed ID: 10029506
[TBL] [Abstract][Full Text] [Related]
9. Outpatient cancer drug costs: changes, drivers, and the future.
Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW
Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485
[TBL] [Abstract][Full Text] [Related]
10. Predictive modeling of total healthcare costs using pharmacy claims data: a comparison of alternative econometric cost modeling techniques.
Powers CA; Meyer CM; Roebuck MC; Vaziri B
Med Care; 2005 Nov; 43(11):1065-72. PubMed ID: 16224298
[TBL] [Abstract][Full Text] [Related]
11. Short-term persistence of high health care costs in a nationally representative sample of children.
Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
[TBL] [Abstract][Full Text] [Related]
12. Analysis of predictive value of four risk models in Medicaid recipients with chronic obstructive pulmonary disease in Texas.
Yarger S; Rascati K; Lawson K; Barner J; Leslie R
Clin Ther; 2008; 30 Spec No():1051-7. PubMed ID: 18640479
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.
Stock SA; Stollenwerk B; Redaelli M; Civello D; Lauterbach KW
J Womens Health (Larchmt); 2008 Apr; 17(3):343-54. PubMed ID: 18338965
[TBL] [Abstract][Full Text] [Related]
14. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes.
Petersen LA; Pietz K; Woodard LD; Byrne M
Med Care; 2005 Jan; 43(1):61-7. PubMed ID: 15626935
[TBL] [Abstract][Full Text] [Related]
16. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
17. Time to death and health expenditure: an improved model for the impact of demographic change on health care costs.
Seshamani M; Gray A
Age Ageing; 2004 Nov; 33(6):556-61. PubMed ID: 15308460
[TBL] [Abstract][Full Text] [Related]
18. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222
[TBL] [Abstract][Full Text] [Related]
19. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
20. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.
Stensland MD; Jacobson JG; Nyhuis A
J Affect Disord; 2007 Aug; 101(1-3):187-93. PubMed ID: 17254637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
